Host: HEK293 cells • AA: 22-124 • MW: 11.61 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Cholera Toxin B Subunit (recombinant)

Item No. 46349

Technical Information
Synonyms
  • Cholera Enterotoxin B Chain
  • Cholera Enterotoxin Gamma Chain
  • Cholera Enterotoxin Subunit B
  • Choleragenoid
  • CTB
  • CTxB
Purity
≥90% estimated by SDS-PAGE
Endotoxin Testing
<0.5 EU/mg, determined by the LAL endotoxin assay (ultralow endotoxin level)
Source
Recombinant CTB expressed in HEK293 cells
Amino Acids
22-124
MW
11.61 kDa
1x PBS, pH 7.4
UniProt Accession №
P01556
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Cholera toxin is produced by V. cholerae and is a multimeric enterotoxin that consists of a single A subunit surrounded by five B subunits.1,2 The non-toxic pentameric B subunit of cholera toxin binds to ganglioside GM1 (Item No. 19579), which acts as a receptor on mammalian cells, and facilitates entrance of the toxic A subunit into cells.3,1 Cholera toxin B subunit (CTB) has been widely used in glycosphingolipid and membrane biology to study lipid rafts, nanodomain assembly, membrane organization and curvature, clathrin-independent endocytosis, and retrograde trafficking in the central nervous system (CNS) either alone or conjugated to a reporter.4,5,6 It has also been used as a carrier protein and an adjuvant, where it increases IgA immune responses, antigen presentation, B cell differentiation, and T cell proliferation.7,8 Formulations containing recombinant CTB have been used as cholera vaccines. Cayman’s Cholera Toxin B Subunit (recombinant) protein can be used for binding assay, cell-based assay, and Western blot (WB) applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Cho, J.A., Chinnapen, D.J.F., Amar, E., et al. Insights on the trafficking and retro-translocation of glycosphingolipid-binding bacterial toxins. Front. Cell. Infect. Microbiol. 2(51), (2012).

    2. Baldauf, K.J., Royal, J.M., Hamorsky, K.T., et al. Cholera toxin B: One subunit with many pharmaceutical applications. Toxins (Basel) 7(3), 974-996 (2015).

    3. Turnbull, W.B., Precious, B.L., and Homans, S.W. Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry. J. Am. Chem. Soc. 126(4), 1047-1054 (2004).

    4. Blank, N., Schiller, M., Krienke, S., et al. Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1. Immunol. Cell Biol. 85(5), 378-382 (2007).

    5. Kenworthy, A.K., Schmieder, S.S., Raghunathan, K., et al. Cholera toxin as a probe for membrane biology. Toxins (Basel) 13(8), 543 (2021).

    6. Luppi, P.-H., Fort, P., and Jouvet, M. Iontophoretic application of unconjugated cholera toxin B subunit (CTb) combined with immunohistochemistry of neurochemical substances: A method for transmitter identification of retrogradely labeled neurons. Brain Res. 534(1-2), 209-224 (1990).

    7. Siriwardhana, C., Bajracharya, A., Seal, F., et al. Evaluation of cholera toxin B subunit as a novel carrier protein for polysaccharide conjugate vaccines. Vaccines (Basel) 13(11), 1159 (2025).

    8. Holmgren, J., Lycke, N., and Czerkinsky, C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11(12), 1179-1184 (1993).